ABBV vs GE: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and GE Aerospace — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-17.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
GE Aerospace · Industrials
$312.90
+3.4% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
GE has more upside to fair value
(+3.4%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
GE |
| Current Price |
$261.70 |
$312.90 |
| Fair Value Estimate |
$259.04 |
$323.41 |
| Upside to Fair Value |
-1.0%
|
+3.4%
|
| Market Cap |
$462.4B |
$324.6B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
27.4x
|
| Price / Sales |
7.2x
|
6.4x
|
| Price / FCF |
23.6x
|
38.7x
|
| Revenue Growth YoY |
+10.2%
|
+21.1%
|
| Gross Margin |
71.5%
|
35.4%
|
| Operating Margin |
29.3%
|
20.8%
|
| Return on Equity |
-136.5%
|
49.0%
|
| Dividend Yield |
2.61% |
0.53% |
| FCF Yield |
4.25%
|
2.58%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
GE Aerospace is a high-quality commercial and military propulsion company whose approximately 50,000 commercial-engine and 30,000 military-engine installed base, long-term service agreements, proprietary repair capabilities and certification barriers support recurring aftermarket economics. The business is executing strongly: revenue grew 21.1% year over year in the most recent quarter, while Q2 …
Accumulation Zones
| Metric |
ABBV |
GE |
| Zone Low |
$194.28 |
$242.56 |
| Zone High |
$220.18 |
$274.90 |
| In Buy Zone? |
No
|
No
|